{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:10:37Z","timestamp":1792026637213,"version":"4.4.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD079125"],"award-info":[{"award-number":["U54HD079125"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD074346"],"award-info":[{"award-number":["R01HD074346"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["UL1TR001860"],"award-info":[{"award-number":["UL1TR001860"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The evaluation of treatment efficacy for individuals with fragile X syndrome (FXS) or intellectual disability (ID) more generally has been hampered by the lack of adequate outcome measures. We evaluated expressive language sampling (ELS) as a procedure for generating outcome measures for treatment research in FXS. We addressed: (a) feasibility, (b) practice effects over two administrations, (c) test-retest reliability over the repeated administrations, and (d) construct validity. We addressed these issues for the full sample as well as for subgroups defined by age, IQ, and ASD status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Participants were 106 individuals with FXS between ages 6 and 23\u2009years who had IQs within the range of intellectual disability (IQ<jats:underline>&lt;<\/jats:underline>\u200970). ELS procedures for collecting samples in conversation and narration were followed and analyzed separately. Five measures were derived from transcripts segmented into C-units (i.e., an independent clause and its modifiers): number of C-units per minute (talkativeness), number of different word roots (vocabulary), C-unit length in morphemes (syntax), percentage of C-units containing dysfluency (utterance planning), and percentage of C-units that were fully or partly unintelligible (articulatory quality). ELS procedures were administered twice at 4-week intervals for each participant. Standardized tests and informant reports were administered and provided measures for evaluating construct validity of ELS measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found low rates of noncompliance, suggesting the task can be completed meaningfully by most individuals with FXS, although noncompliance was higher for younger, lower IQ, and more autistic participants. Minimal practice effects and strong test-retest reliability over the 4-week interval were observed for the full sample and across the range of ages, IQs, and autism symptom severity. Evidence of convergent construct validity was observed for the measures of vocabulary, syntax, and unintelligibility for the full sample and across the range of IQ and autism symptom severity, but not for participants under age 12. Conversation and narration yielded largely similar results in all analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The findings suggest that the ELS procedures are feasible and yield measures with adequate psychometric properties for a majority of 6 to 23\u00a0years with FXS who have ID. The procedures work equally well regardless of level of ID or degree of ASD severity. The procedures, however, are more challenging and have somewhat less adequate psychometric properties for individuals with FXS under age 12.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s11689-020-09313-6","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T18:03:03Z","timestamp":1584986583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Expressive language sampling as a source of outcome measures for treatment studies in fragile X syndrome: feasibility, practice effects, test-retest reliability, and construct validity"],"prefix":"10.1186","volume":"12","author":[{"given":"Leonard","family":"Abbeduto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie O.","family":"Edgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"McDuffie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Aschkenasy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela John","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"key":"9313_CR1","doi-asserted-by":"crossref","unstructured":"Van Naarden Braun K, Christensen D, Doernberg N, Schieve L, Rice C, Wiggins L, et al. Trends in the prevalence of autism spectrum disorder, cerebral palsy, hearing loss, intellectual disability, and vision impairment, Metropolitan Atlanta, 1991\u20132010. Pavlova MA, editor. PLoS One. 2015;10(4):e0124120. Available from: https:\/\/dx.plos.org\/10.1371\/journal.pone.0124120.","DOI":"10.1371\/journal.pone.0124120"},{"key":"9313_CR2","first-page":"13","volume-title":"Genetic, behavioural, and inclusion aspects of intellectual disabilities","author":"RM Hodapp","year":"2004","unstructured":"Hodapp RM, Dykens EM. Genetic and behavioural aspects: application to maladaptive behaviour and cognition. In: Genetic, behavioural, and inclusion aspects of intellectual disabilities. London: Whurr Publishers; 2004. p. 13\u201348."},{"issue":"1","key":"9313_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrg3999","volume":"17","author":"LELM Vissers","year":"2016","unstructured":"Vissers LELM, Gilissen C, Veltman JA. Genetic studies in intellectual disability and related disorders. Nat Rev Genet. 2016;17(1):9\u201318 Available from: http:\/\/www.nature.com\/articles\/nrg3999.","journal-title":"Nat Rev Genet"},{"key":"9313_CR4","unstructured":"Dykens EM. Behavioral phenotypes and genomic testing: scientific and societal implications. In: Glidden LM, Abbeduto L, McIntyre L, Tasee M, editors. Handbook of intellectual and developmental disabilities. Washington: American Psychological Association Press. In press."},{"key":"9313_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3389\/fgene.2018.00424","volume":"9","author":"L del Hoyo Soriano","year":"2018","unstructured":"del Hoyo Soriano L, Thurman AJ, Abbeduto L. Specificity: a phenotypic comparison of communication-relevant domains between youth with down syndrome and fragile X syndrome. Front Genet. 2018;9:424 Available from: https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2018.00424\/full.","journal-title":"Front Genet"},{"issue":"4","key":"9313_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nrd.2017.221","volume":"17","author":"EM Berry-Kravis","year":"2018","unstructured":"Berry-Kravis EM, Lindemann L, J\u00f8nch AE, Apostol G, Bear MF, Carpenter RL, et al. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018;17(4):280\u201399 Available from: http:\/\/www.nature.com\/articles\/nrd.2017.221.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9313_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1352\/1944-7558-122.3.247","volume":"122","author":"AJ Esbensen","year":"2017","unstructured":"Esbensen AJ, Hooper SR, Fidler D, Hartley SL, Edgin J, D\u2019Ardhuy XL, et al. Outcome measures for clinical trials in down syndrome. Am J Intellect Dev Disabil. 2017;122(3):247\u201381.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"16","key":"9313_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.0000000000007301","volume":"92","author":"R Hagerman","year":"2019","unstructured":"Hagerman R, Tuchman R. Turning the tide on targeted treatments for neurodevelopmental disorders. Neurol Int. 2019;92(16):741\u20132 Available from: http:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000007301.","journal-title":"Neurol Int"},{"key":"9313_CR9","unstructured":"Abbeduto L, Thurman AJ, del Hoyo Soriano L, Klusek J. Fragile X syndrome and associated disorders. In: Glidden LM, Abbeduto L, McIntyre L, Tasee M, editors. Handbook of intellectual and developmental disabilities. Washington: American Psychological Association Press. In press."},{"issue":"3","key":"9313_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mrdd.20166","volume":"13","author":"DJ Fidler","year":"2007","unstructured":"Fidler DJ, Nadel L. Education and children with Down syndrome: neuroscience, development, and intervention. Ment Retard Dev Disabil Res Rev. 2007;13(3):262\u201371 Available from: http:\/\/doi.wiley.com\/10.1002\/mrdd.20166.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"1","key":"9313_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s11689-017-9186-9","volume":"9","author":"CA Erickson","year":"2017","unstructured":"Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, et al. Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord. 2017;9(1):7 Available from: http:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-017-9186-9.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9313_CR12","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Prim. 2017;3(1):17065 Available from: http:\/\/www.nature.com\/articles\/nrdp201765.","journal-title":"Nat Rev Dis Prim"},{"issue":"4","key":"9313_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ajhg.2009.09.007","volume":"85","author":"B Coffee","year":"2009","unstructured":"Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, et al. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009;85(4):503\u201314 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929709004030.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"9313_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00125817-200109000-00006","volume":"3","author":"DC Crawford","year":"2001","unstructured":"Crawford DC, Acu\u00f1a JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med. 2001;3(5):359\u201371 Available from: http:\/\/www.nature.com\/doifinder\/10.1097\/00125817-200109000-00006.","journal-title":"Genet Med"},{"issue":"4","key":"9313_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2353\/jmoldx.2009.080173","volume":"11","author":"I Fernandez-Carvajal","year":"2009","unstructured":"Fernandez-Carvajal I, Walichiewicz P, Xiaosen X, Pan R, Hagerman PJ, Tassone F. Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population. J Mol Diagnostics. 2009;11(4):324\u20139 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157810602462.","journal-title":"J Mol Diagnostics"},{"issue":"1","key":"9313_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s11689-017-9193-x","volume":"9","author":"DB Budimirovic","year":"2017","unstructured":"Budimirovic DB, Berry-Kravis E, Erickson CA, Hall SS, Hessl D, Reiss AL, et al. Updated report on tools to measure outcomes of clinical trials in fragile X syndrome. J Neurodev Disord. 2017;9(1):14 Available from: http:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-017-9193-x.","journal-title":"J Neurodev Disord"},{"key":"9313_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1017\/CBO9780511919299.004","volume-title":"Neurocognitive rehabilitation of down syndrome","author":"J Edgin","year":"2011","unstructured":"Edgin J, Span\u014d G, Nadel L. Advances in clinical endpoints for neurocognitive rehabilitation in Down syndrome. In: Rondal J-A, Perera J, Spiker D, editors. Neurocognitive rehabilitation of down syndrome. Cambridge: Cambridge University Press; 2011. p. 36\u201351. Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9780511919299A013\/type\/book_part."},{"issue":"11","key":"9313_CR18","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/ajmg.a.38465","volume":"173","author":"SJ Hart","year":"2017","unstructured":"Hart SJ, Visootsak J, Tamburri P, Phuong P, Baumer N, Hernandez M-C, et al. Pharmacological interventions to improve cognition and adaptive functioning in down syndrome: strides to date. Am J Med Genet Part A. 2017;173(11):3029\u201341 Available from: http:\/\/doi.wiley.com\/10.1002\/ajmg.a.38465.","journal-title":"Am J Med Genet Part A"},{"issue":"7","key":"9313_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/DBP.0b013e31829d1f20","volume":"34","author":"E Berry-Kravis","year":"2013","unstructured":"Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK. Outcome measures for clinical trials in fragile X syndrome. J Dev Behav Pediatr. 2013;34(7):508\u201322.","journal-title":"J Dev Behav Pediatr"},{"issue":"152","key":"9313_CR20","doi-asserted-by":"publisher","first-page":"152ra127","DOI":"10.1126\/scitranslmed.3004214","volume":"4","author":"EM Berry-Kravis","year":"2012","unstructured":"Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, et al. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med. 2012;4(152):152ra127 [cited 2020 Feb 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22993294.","journal-title":"Sci Transl Med"},{"issue":"321","key":"9313_CR21","doi-asserted-by":"publisher","first-page":"321ra5","DOI":"10.1126\/scitranslmed.aab4109","volume":"8","author":"E Berry-Kravis","year":"2016","unstructured":"Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, et al. Mavoglurant in fragile X syndrome: results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016;8(321):321ra5 [cited 2020 Feb 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26764156.","journal-title":"Sci Transl Med"},{"issue":"1","key":"9313_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s11689-016-9167-4","volume":"8","author":"D Hessl","year":"2016","unstructured":"Hessl D, Sansone SM, Berry-Kravis E, Riley K, Widaman KF, Abbeduto L, et al. The NIH Toolbox Cognitive Battery for intellectual disabilities: three preliminary studies and future directions. J Neurodev Disord. 2016;8(1):35 Available from: http:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-016-9167-4.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9313_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1866-1955-6-16","volume":"6","author":"SM Sansone","year":"2014","unstructured":"Sansone SM, Schneider A, Bickel E, Berry-Kravis E, Prescott C, Hessl D. Improving IQ measurement in intellectual disabilities using true deviation from population norms. J Neurodev Disord. 2014;6(1):16 Available from: http:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/1866-1955-6-16.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"9313_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11689-008-9001-8","volume":"1","author":"D Hessl","year":"2009","unstructured":"Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, et al. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord. 2009;1(1):33\u201345 Available from: http:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1007\/s11689-008-9001-8.","journal-title":"J Neurodev Disord"},{"issue":"2","key":"9313_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/1087054715571739","volume":"23","author":"LC Chromik","year":"2019","unstructured":"Chromik LC, Quintin E-M, Lepage J-F, Hustyi KM, Lightbody AA, Reiss AL. The influence of hyperactivity, impulsivity, and attention problems on social functioning in adolescents and young adults with fragile X syndrome. J Atten Disord. 2019;23(2):181\u20138 Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/1087054715571739.","journal-title":"J Atten Disord"},{"issue":"3","key":"9313_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jemt.10070","volume":"57","author":"CS Keysor","year":"2002","unstructured":"Keysor CS, Mazzocco MM. A developmental approach to understanding fragile X syndrome in females. Microsc Res Tech. 2002;57(3):179\u201386 Available from: http:\/\/doi.wiley.com\/10.1002\/jemt.10070.","journal-title":"Microsc Res Tech"},{"issue":"4","key":"9313_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1017\/S0140525X10001019","volume":"33","author":"TM Dekker","year":"2010","unstructured":"Dekker TM, Karmiloff-Smith A. The importance of ontogenetic change in typical and atypical development. Behav Brain Sci. 2010;33(4):271\u20132 Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/S0140525X10001019\/type\/journal_article.","journal-title":"Behav Brain Sci"},{"issue":"7","key":"9313_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/87565641.2013.820305","volume":"38","author":"ST Kover","year":"2013","unstructured":"Kover ST, Pierpont EI, Kim J-S, Ted Brown W, Abbeduto L. A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome. Dev Neuropsychol. 2013;38(7):445\u201360.","journal-title":"Dev Neuropsychol"},{"issue":"12","key":"9313_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/brainsci8120224","volume":"8","author":"C Erickson","year":"2018","unstructured":"Erickson C, Kaufmann W, Budimirovic D, Lachiewicz A, Haas-Givler B, Miller R, et al. Best practices in fragile X syndrome treatment development. Brain Sci. 2018;8(12):224 Available from: http:\/\/www.mdpi.com\/2076-3425\/8\/12\/224.","journal-title":"Brain Sci"},{"key":"9313_CR30","doi-asserted-by":"crossref","unstructured":"Barokova M, Tager-Flusberg H. Commentary: measuring language change through natural language samples. J Autism Dev Disord. 2018; Available from: http:\/\/link.springer.com\/10.1007\/s10803-018-3628-4.","DOI":"10.1007\/s10803-018-3628-4"},{"issue":"5","key":"9313_CR31","first-page":"279","volume":"33","author":"L Abbeduto","year":"1995","unstructured":"Abbeduto L, Benson G, Short K, Dolish J. Effects of sampling context on the expressive language of children and adolescents with mental retardation. Ment Retard. 1995;33(5):279\u201388.","journal-title":"Ment Retard"},{"issue":"4","key":"9313_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/DBP.0b013e31828742fc","volume":"34","author":"E Berry-Kravis","year":"2013","unstructured":"Berry-Kravis E, Doll E, Sterling A, Kover ST, Schroeder SM, Mathur S, et al. Development of an expressive language sampling procedure in fragile X syndrome: a pilot study. J Dev Behav Pediatr. 2013;34(4):245\u201351 Available from: http:\/\/content.wkhealth.com\/linkback\/openurl?sid=WKPTLP:landingpage&an=00004703-201305000-00004.","journal-title":"J Dev Behav Pediatr"},{"key":"9313_CR33","volume-title":"Studying the language development of children with intellectual disabilities. Research methods in child language: a practical guide","author":"L Abbeduto","year":"2012","unstructured":"Abbeduto L, Kover ST, Mcduffie A. Studying the language development of children with intellectual disabilities. Research methods in child language: a practical guide; 2012."},{"issue":"4","key":"9313_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1044\/1092-4388(2011\/11-0075)","volume":"55","author":"ST Kover","year":"2012","unstructured":"Kover ST, McDuffie A, Abbeduto L, Brown WT. Effects of sampling context on spontaneous expressive language in males with fragile X syndrome or down syndrome. J Speech Lang Hear Res. 2012;55(4):1022\u201338 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/1092-4388%282011\/11-0075%29.","journal-title":"J Speech Lang Hear Res"},{"key":"9313_CR35","first-page":"1","volume-title":"International review of research in mental retardation. Elsevier","author":"L Abbeduto","year":"2006","unstructured":"Abbeduto L, Keller-Bell Y, Richmond EK, Murphy MM. Research on language development and mental retardation: history, theories, findings, and future directions*. In: International review of research in mental retardation. Elsevier; 2006. p. 1\u201339. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074775006320010."},{"key":"9313_CR36","doi-asserted-by":"crossref","unstructured":"Abbeduto L, McDuffie A, Thurman AJ, Kover ST. Language development in individuals with intellectual and developmental disabilities: from phenotypes to treatments. Vol. 50, International Review of Research in Developmental Disabilities. 2016.","DOI":"10.1016\/bs.irrdd.2016.05.006"},{"key":"9313_CR37","volume-title":"Mullen scales of early learning","author":"EM Mullen","year":"1995","unstructured":"Mullen EM. Mullen scales of early learning. Circle Pines: AGS; 1995."},{"key":"9313_CR38","volume-title":"Peabody picture vocabulary test","author":"DM Dunn","year":"2007","unstructured":"Dunn DM, Dunn LM. Peabody picture vocabulary test. 4th ed. Minneapolis: Pearson; 2007.","edition":"4"},{"key":"9313_CR39","unstructured":"IL Z, VG S, Pond RE. Preschool Language Scale-5th edition. Saddle River: Pearson; 2011."},{"key":"9313_CR40","volume-title":"Clinical evaluation of language fundamentals","author":"E Semel","year":"2003","unstructured":"Semel E, Wiig E, Secord W. Clinical evaluation of language fundamentals. 4th ed. Saddle River: Pearson; 2003.","edition":"4"},{"key":"9313_CR41","volume-title":"Comprehensive assessment of spoken language","author":"E Carrow-Wollfolk","year":"1999","unstructured":"Carrow-Wollfolk E. Comprehensive assessment of spoken language. Circle Pines: AGS; 1999."},{"issue":"8","key":"9313_CR42","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/DBP.0000000000000334","volume":"37","author":"L Greiss Hess","year":"2016","unstructured":"Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, et al. A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome. J Dev Behav Pediatr. 2016;37(8):619\u201328.","journal-title":"J Dev Behav Pediatr"},{"issue":"11","key":"9313_CR43","doi-asserted-by":"publisher","first-page":"e956","DOI":"10.1002\/mgg3.956","volume":"7","author":"HMB Biag","year":"2019","unstructured":"Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, et al. Metformin treatment in young children with fragile X syndrome. Mol Genet genomic Med. 2019;7(11):e956 [cited 2019 Dec 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31520524.","journal-title":"Mol Genet genomic Med"},{"key":"9313_CR44","doi-asserted-by":"crossref","unstructured":"Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Nelson S, et al. Controlled trial of lovastatin combined with an open label treatment of a parentimplemented language intervention in youth with fragile X syndrome. Sacramento; 2020.","DOI":"10.1186\/s11689-020-09315-4"},{"issue":"5","key":"9313_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/cap.2006.16.525","volume":"16","author":"E Berry-Kravis","year":"2006","unstructured":"Berry-Kravis E, Krause SE, Block SS, Guter S, Wuu J, Leurgans S, et al. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006;16(5):525\u201340 [cited 2020 Feb 15] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17069542.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"9313_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/14417040400010140","volume":"6","author":"MF Westerveld","year":"2004","unstructured":"Westerveld MF, Gillon GT, Miller JF. Spoken language samples of New Zealand children in conversation and narration. Adv Speech Lang Pathol. 2004;6(4):195\u2013208 Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14417040400010140.","journal-title":"Adv Speech Lang Pathol"},{"issue":"4","key":"9313_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1044\/jslhr.4004.765","volume":"40","author":"G Conti-Ramsden","year":"1997","unstructured":"Conti-Ramsden G, Crutchley A, Botting N. The extent to which psychometric tests differentiate subgroups of children with SLI. J Speech, Lang Hear Res. 1997;40(4):765\u201377 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/jslhr.4004.765.","journal-title":"J Speech, Lang Hear Res"},{"issue":"3","key":"9313_CR48","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1044\/jslhr.4003.556","volume":"40","author":"L Rescorla","year":"1997","unstructured":"Rescorla L, Roberts J, Dahlsgaard K. Late talkers at 2: outcome at age 3. J Speech, Lang Hear Res. 1997;40(3):556\u201366 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/jslhr.4003.556.","journal-title":"J Speech, Lang Hear Res"},{"issue":"4","key":"9313_CR49","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1044\/1092-4388(2006\/056)","volume":"49","author":"ML Rice","year":"2006","unstructured":"Rice ML, Redmond SM, Hoffman L. Mean length of utterance in children with specific language impairment and in younger control children shows concurrent validity and stable and parallel growth trajectories. J Speech Lang Hear Res. 2006;49(4):793\u2013808 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/1092-4388%282006\/056%29.","journal-title":"J Speech Lang Hear Res"},{"issue":"2","key":"9313_CR50","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1044\/1092-4388(2009\/08-0183)","volume":"53","author":"ML Rice","year":"2010","unstructured":"Rice ML, Smolik F, Perpich D, Thompson T, Rytting N, Blossom M. Mean length of utterance levels in 6-month intervals for children 3 to 9 years with and without language impairments. J Speech, Lang Hear Res. 2010;53(2):333\u201349 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/1092-4388%282009\/08-0183%29.","journal-title":"J Speech, Lang Hear Res"},{"issue":"2","key":"9313_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1044\/jslhr.4302.366","volume":"43","author":"HK Craig","year":"2000","unstructured":"Craig HK, Washington JA. An assessment battery for identifying language impairments in African American children. J Speech Lang Hear Res. 2000;43(2):366\u201379 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/jslhr.4302.366.","journal-title":"J Speech Lang Hear Res"},{"issue":"3","key":"9313_CR52","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s10803-014-2242-3","volume":"45","author":"DM Casenhiser","year":"2015","unstructured":"Casenhiser DM, Binns A, McGill F, Morderer O, Shanker SG. Measuring and supporting language function for children with autism: evidence from a randomized control trial of a social-interaction-based therapy. J Autism Dev Disord. 2015;45(3):846\u201357 Available from: http:\/\/link.springer.com\/10.1007\/s10803-014-2242-3.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"9313_CR53","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1044\/1092-4388(2012\/11-0231)","volume":"56","author":"AP Kaiser","year":"2013","unstructured":"Kaiser AP, Roberts MY. Parent-implemented enhanced milieu teaching with preschool children who have intellectual disabilities. J Speech Lang Hear Res. 2013;56(1):295\u2013309 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/1092-4388%282012\/11-0231%29.","journal-title":"J Speech Lang Hear Res"},{"issue":"2","key":"9313_CR54","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/01.TLD.0000318937.39301.76","volume":"28","author":"J Heilmann","year":"2008","unstructured":"Heilmann J, Miller JF, Iglesias A, Fabiano-Smith L, Nockerts A, Andriacchi KD. Narrative transcription accuracy and reliability in two languages. Top Lang Disord. 2008;28(2):178\u201388 Available from: https:\/\/insights.ovid.com\/crossref?an=00011363-200804000-00009.","journal-title":"Top Lang Disord"},{"issue":"4","key":"9313_CR55","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0265532209355669","volume":"27","author":"J Heilmann","year":"2010","unstructured":"Heilmann J, Miller JF, Nockerts A. Sensitivity of narrative organization measures using narrative retells produced by young school-age children. Lang Test. 2010;27(4):603\u201326 Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/0265532209355669.","journal-title":"Lang Test"},{"issue":"4","key":"9313_CR56","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1044\/0161-1461(2009\/09-0023)","volume":"41","author":"J Heilmann","year":"2010","unstructured":"Heilmann J, Nockerts A, Miller JF. Language sampling: does the length of the transcript matter? Lang Speech Hear Serv Sch. 2010;41(4):393\u2013404 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/0161-1461%282009\/09-0023%29.","journal-title":"Lang Speech Hear Serv Sch"},{"issue":"2","key":"9313_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1044\/jshr.2402.154","volume":"24","author":"JF Miller","year":"1981","unstructured":"Miller JF, Chapman RS. The relation between age and mean length of utterance in morphemes. J Speech Lang Hear Res. 1981;24(2):154\u201361 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/jshr.2402.154.","journal-title":"J Speech Lang Hear Res"},{"issue":"3","key":"9313_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/S0305000900010229","volume":"14","author":"JA Rondal","year":"1987","unstructured":"Rondal JA, Ghiotto M, Bredart S, Bachelet J-F. Age-relation, reliability and grammatical validity of measures of utterance length. J Child Lang. 1987;14(3):433\u201346 Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/S0305000900010229\/type\/journal_article.","journal-title":"J Child Lang"},{"key":"9313_CR59","unstructured":"Sparrow SS, Cicchetti D, Balla DA. Vineland adaptive behavior scales, second edition: American Psychological Association; 2012. Available from: http:\/\/doi.apa.org\/getdoi.cfm?doi=10.1037\/t15164-000."},{"key":"9313_CR60","volume-title":"Stanford Binet intelligence scales","author":"G Roid","year":"2003","unstructured":"Roid G. Stanford Binet intelligence scales. 5th ed. Rolling Meadows: Riverside Publishing; 2003.","edition":"5"},{"key":"9313_CR61","unstructured":"Lord C, Rutter M, DiLavore P, Risi S, Gotham K, Bishop SL. Autism diagnostic observation schedule-Second edition (ADOS-2). Westner Psychological Services, Torrance."},{"issue":"1","key":"9313_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1044\/2017_AJSLP-17-0046","volume":"27","author":"MM Channell","year":"2018","unstructured":"Channell MM, Loveall SJ, Conners FA, Harvey DJ, Abbeduto L. Narrative language sampling in typical development: implications for clinical trials. Am J Speech-Language Pathol. 2018;27(1):123\u201335 Available from: http:\/\/pubs.asha.org\/doi\/10.1044\/2017_AJSLP-17-0046.","journal-title":"Am J Speech-Language Pathol"},{"issue":"1","key":"9313_CR63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1017\/S0305000912000207","volume":"40","author":"LH Finestack","year":"2013","unstructured":"Finestack LH, Sterling AM, Abbeduto L. Discriminating Down syndrome and fragile X syndrome based on language ability. J Child Lang. 2013;40(1):244\u201365 Available from: https:\/\/www.cambridge.org\/core\/product\/identifier\/S0305000912000207\/type\/journal_article.","journal-title":"J Child Lang"},{"issue":"3","key":"9313_CR64","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2788.2010.01255.x","volume":"54","author":"ST Kover","year":"2010","unstructured":"Kover ST, Abbeduto L. Expressive language in male adolescents with fragile X syndrome with and without comorbid autism. J Intellect Disabil Res. 2010;54(3):246\u201365 Available from: http:\/\/doi.wiley.com\/10.1111\/j.1365-2788.2010.01255.x.","journal-title":"J Intellect Disabil Res"},{"issue":"5","key":"9313_CR65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2788.2006.00888.x","volume":"51","author":"MM Murphy","year":"2007","unstructured":"Murphy MM, Abbeduto L. Gender differences in repetitive language in fragile X syndrome. J Intellect Disabil Res. 2007;51(5):387\u2013400.","journal-title":"J Intellect Disabil Res"},{"key":"9313_CR66","unstructured":"Miller J, Iglesias A. Systematic analysis of language transcripts (SALT), Research Version 2018 [Computer Software]. Middleton: SALT Software, LLC.; 2018."},{"key":"9313_CR67","volume-title":"Language development: kindergarten through age twelve","author":"W Loban","year":"1976","unstructured":"Loban W. Language development: kindergarten through age twelve. Urbana: National Council of Teachers of English; 1976."},{"key":"9313_CR68","volume-title":"Assessing language production using SALT software a clinician\u2019s guide to language sample analysis","author":"JF Miller","year":"2015","unstructured":"Miller JF, Anriacchi K, Nockerts N. Assessing language production using SALT software a clinician\u2019s guide to language sample analysis. Middleton: SALT Software, LLC; 2015. Apprendix N."},{"key":"9313_CR69","volume-title":"Clinical evaluation of language fundamentals - 5th edition","author":"EH Wiig","year":"2013","unstructured":"Wiig EH, Semel E, Secord WA. Clinical evaluation of language fundamentals - 5th edition. Bloomington: NCS Pearson; 2013."},{"key":"9313_CR70","volume-title":"Goldman-Fristoe test of articulation","author":"R Goldman","year":"1986","unstructured":"Goldman R, Fristoe M. Goldman-Fristoe test of articulation. Circle Pines: American Guidance Service; 1986."},{"issue":"1","key":"9313_CR71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc Ser B"},{"key":"9313_CR72","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1044\/1092-4388(2001\/089)","volume":"44","author":"M Rispoli","year":"2001","unstructured":"Rispoli M, Hadley P. The leading-edge: the significance of sentence disruptions in the development of grammar. J Speech Lang Hear Res. 2001;44:1131\u201343.","journal-title":"J Speech Lang Hear Res."},{"key":"9313_CR73","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988."},{"issue":"3","key":"9313_CR74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1352\/1944-7558-122.3.215","volume":"122","author":"JO Edgin","year":"2017","unstructured":"Edgin JO, Anand P, Rosser T, Pierpont EI, Figueroa C, Hamilton D, et al. The Arizona cognitive test battery for down syndrome: test-retest reliability and practice effects. Am J Intellect Dev Disabil. 2017;122(3):215\u201334.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"4","key":"9313_CR75","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1044\/1092-4388(2009\/08-0001)","volume":"52","author":"E Barnes","year":"2009","unstructured":"Barnes E, Roberts J, Long SH, Martin GE, Berni MC, Mandulak KC, et al. Phonological accuracy and intelligibility in connected speech of boys with fragile X syndrome or Down syndrome. J Speech Lang Hear Res. 2009;52(4):1048\u201361.","journal-title":"J Speech Lang Hear Res"},{"issue":"2","key":"9313_CR76","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/brainsci10020066","volume":"10","author":"RC Shaffer","year":"2020","unstructured":"Shaffer RC, Schmitt L, John Thurman A, Abbeduto L, Hong M, Pedapati E, et al. The relationship between expressive language sampling and clinical measures in fragile X syndrome and typical development. Brain Sci. 2020;10(2):66 [cited 2020 Feb 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31991905.","journal-title":"Brain Sci"},{"issue":"1","key":"9313_CR77","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bandc.2013.02.009","volume":"82","author":"AM Sterling","year":"2013","unstructured":"Sterling AM, Mailick M, Greenberg J, Warren SF, Brady N. Language dysfluencies in females with the FMR1 premutation. Brain Cogn. 2013;82(1):84\u20139 [cited 2020 Feb 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23523717.","journal-title":"Brain Cogn"},{"issue":"3","key":"9313_CR78","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10803-015-2651-y","volume":"46","author":"CA Irvine","year":"2016","unstructured":"Irvine CA, Eigsti I-M, Fein DA. Uh, um, and autism: filler disfluencies as pragmatic markers in adolescents with optimal outcomes from autism spectrum disorder. J Autism Dev Disord. 2016;46(3):1061\u201370 [cited 2020 Feb 9] Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26586555.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"9313_CR79","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/17518423.2017.1369189","volume":"21","author":"A McDuffie","year":"2018","unstructured":"McDuffie A, Banasik A, Bullard L, Nelson S, Feigles RT, Hagerman R, et al. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Dev Neurorehabil. 2018;21(1):48\u201363 Available from: https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17518423.2017.1369189.","journal-title":"Dev Neurorehabil"},{"key":"9313_CR80","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S0305000905006926","volume":"32","author":"K McGregor","year":"2005","unstructured":"McGregor K, Sheng L, Smith B. The precocious two year old: status of the lexicon and links to grammar. J Child Lang. 2005;32:563\u201385.","journal-title":"J Child Lang"},{"key":"9313_CR81","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1044\/1092-4388(2009\/08-0136)","volume":"52","author":"H Tager-Flusberg","year":"2009","unstructured":"Tager-Flusberg H, Rogers S, Cooper J, Landa R, Lord C, Paul R, et al. Defining spoken language benchmarks and selecting measures of expressive language development for young children with autism spectrum disorders. J Speech Lang Hear Res. 2009;52:643\u201352.","journal-title":"J Speech Lang Hear Res."},{"issue":"1","key":"9313_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10803-008-0601-7","volume":"39","author":"LB Adamson","year":"2009","unstructured":"Adamson LB, Bakeman R, Deckner DF, Romski M. Joint engagement and the emergence of language in children with autism and Down syndrome. J Autism Dev Disord. 2009;39(1):84\u201396 Available from: http:\/\/link.springer.com\/10.1007\/s10803-008-0601-7.","journal-title":"J Autism Dev Disord"},{"key":"9313_CR83","unstructured":"Wetherby AM, Prizant BM. Communication and symbolic behavior scales developmental profile, first normed edition: American Psychological Association; 2012. Available from: http:\/\/doi.apa.org\/getdoi.cfm?doi=10.1037\/t11529-000."},{"issue":"5","key":"9313_CR84","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1352\/1944-7558-124.5.438","volume":"124","author":"MO Mazurek","year":"2019","unstructured":"Mazurek MO, Baker-Ericz\u00e9n M, Kanne SM. Brief report: calculation and convergent and divergent validity of a new ADOS-2 expressive language score. Am J Intellect Dev Disabil. 2019;124(5):438\u201349 Available from: http:\/\/www.aaiddjournals.org\/doi\/10.1352\/1944-7558-124.5.438.","journal-title":"Am J Intellect Dev Disabil"},{"key":"9313_CR85","first-page":"192","volume-title":"All about language: science, theory, and practice","author":"L Abbeduto","year":"2020","unstructured":"Abbeduto L, Bullard L, Nelson S, Banasik A, Tempero Feigles R, Nguyen V, et al. Using technology to bring treatments to families affected by autism and related neurodevelopmental disorders in their communities. In: Grigorenko EL, Shtyrov Y, McCardle P, editors. All about language: science, theory, and practice. Baltimore: Brookes; 2020. p. 192\u2013204."}],"updated-by":[{"DOI":"10.1186\/s11689-020-09314-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000}}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-020-09313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-020-09313-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-020-09313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T19:36:48Z","timestamp":1722627408000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-020-09313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9313"],"URL":"https:\/\/doi.org\/10.1186\/s11689-020-09313-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s11689-020-09314-5","asserted-by":"object"}]},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"19 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this article [1], the author name Leonard Abbeduto was misspelled as Leonardkk Abbeduto. The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at each of the five participating universities of the authors. Informed written consent was obtained from either the participant or the parent\/legal guardian prior to participation and assent was obtained from each participant as appropriate. The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and international committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LA has received funding from F. Hoffmann-La Roche Ltd., Roche TCRC, Inc., Neuren Pharmaceuticals Ltd., Fulcrum Therapeutics, and Lumind to consult on and implement outcome measures in clinical trials for FXS and Down syndrome. EBK has received funding from Seaside Therapeutics, Novartis, Roche, Alcobra, Neuren, Cydan, Fulcrum, GW, Neurotrope, Marinus, Zynerba, BioMarin, Lumos, Ovid, AMO, Yamo, Ionis, GeneTx, Acadia, Neurogene, Ultragenyx, and Vtesse\/Sucampo\/Mallinkcrodt Pharmaceuticals to consult on trial design or development strategies and\/or conduct clinical trials in FXS or other genetic Neurodevelopmental or neurodegenerative disorders, and from Asuragen Inc. to develop testing standards for <i>FMR1<\/i> testing. AJT has received funding from Fulcrum Therapeutics to develop outcome measures for FXS. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}